These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9851186)

  • 1. [Multiple myeloma with hyperammonemia].
    Izumi T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):446-8. PubMed ID: 9851186
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperammonemia and encephalopathy in patients with multiple myeloma.
    Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G
    Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amino acid disturbance in multiple myeloma with hyperammonemia.
    Matsuzaki H; Hata H; Sonoki T; Matsuno F; Kuribayashi N; Yoshida M; Nagasaki A; Murata H; Fujiyama S; Takatsuki K
    Int J Hematol; 1995 Apr; 61(3):131-7. PubMed ID: 7599324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic hyperammonemia after high-dose chemotherapy.
    Fine P; Adler K; Gerstenfeld D
    Am J Med; 1989 May; 86(5):629. PubMed ID: 2712077
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
    Ikewaki J; Ogata M; Imamura T; Kohno K; Nakayama T; Kadota J
    Leuk Lymphoma; 2009 Apr; 50(4):667-9. PubMed ID: 19373670
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperammonemia: elevated ammonia levels in multiple myeloma.
    Holahan JR
    Am J Med; 2004 Feb; 116(3):210-1. PubMed ID: 14749172
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical manifestation of severe hyperammonaemia in patients with multiple myeloma.
    Martinelli G; Peccatori F; Ullrich B; Ghielmini M; Roggero E; Goldhirsch A
    Ann Oncol; 1997 Aug; 8(8):811. PubMed ID: 9332693
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple myeloma with hyperammonemia].
    Horie A; Watanabe T; Miyauchi Y; Irabu T; Yoshida S
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1433-4. PubMed ID: 10934775
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of calcitonin in osteosclerosis of myeloma?
    Rousseau JJ; Heynen G; Franck G
    Arch Intern Med; 1980 Nov; 140(11):1554. PubMed ID: 7436658
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperammonemia after high-dose chemotherapy and stem cell transplantation.
    Frere P; Canivet JL; Gennigens C; Rebeix JP; Fillet G; Beguin Y
    Bone Marrow Transplant; 2000 Aug; 26(3):343-5. PubMed ID: 10967577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonia toxicity to the brain and creatine.
    Bachmann C; Braissant O; Villard AM; Boulat O; Henry H
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S52-7. PubMed ID: 15050974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of multiple myeloma.
    Bladé J; Rosiñol L
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1231-46, xi. PubMed ID: 17996596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation.
    Moffatt-Bruce SD; Pesavento T; Von Viger J; Nunley D; Pope-Harman A; Martin S; Ross P
    J Heart Lung Transplant; 2008 Jul; 27(7):801-3. PubMed ID: 18582813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of M proteins].
    Sasaki R
    Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease.
    Ogata A; Kitano M; Hashimoto N; Iwasaki T; Hamano T; Kakishita E
    J Bone Miner Metab; 2002; 20(4):240-2. PubMed ID: 12115071
    [No Abstract]   [Full Text] [Related]  

  • 20. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.
    Shawcross DL; Balata S; Olde Damink SW; Hayes PC; Wardlaw J; Marshall I; Deutz NE; Williams R; Jalan R
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G503-9. PubMed ID: 15130875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.